MRNA
Moderna, Inc.
Moderna, Inc. (MRNA) has 9 SEC Form 4 filings (33 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is President Hoge Stephen with 3 filings. Insiders have net sold $10.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Stéphane Bancel
- Employees:5,800
- HQ:Cambridge, MA, US
- IPO:2018-12-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10.1M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$26.8B
latest known value
Earnings: last 7 quarters
EstimatedActual
| Source | ||||||
|---|---|---|---|---|---|---|
| President | Sale | 53,336 | $3.6M | Jul 16 | SEC ↗ | |
| President | Sale | 53,336 | $2.7M | Jun 17 | SEC ↗ | |
AFEYAN NOUBARFirst filing | Director | Sale | 9,263 | $434K | May 22 | SEC ↗ |
Hoge StephenFirst filing | President | Sale | 53,336 | $2.6M | May 18 | SEC ↗ |
Klinger Shannon ThymeFirst filing | Chief Legal Officer | Sale | 13,885 | $726K | Mar 3 | SEC ↗ |
Related companies
Moderna, Inc. is in the Healthcare sector.